PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 19, 2019ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)Open Access

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJohn J.V. McMurraySSScott D. SolomonSISilvio E. Inzucchi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

McMurray et al. (2019) studied this question.

synapsesocial.com/papers/69962dc52d01a3089d874e4chttps://doi.org/10.1056/nejmoa1911303
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF)2019 · 451 citations
  2. 2Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015 · 12,268 citations